| pubmed-article:8151495 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8151495 | lifeskim:mentions | umls-concept:C0043474 | lld:lifeskim |
| pubmed-article:8151495 | lifeskim:mentions | umls-concept:C0085880 | lld:lifeskim |
| pubmed-article:8151495 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:8151495 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8151495 | lifeskim:mentions | umls-concept:C0864665 | lld:lifeskim |
| pubmed-article:8151495 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8151495 | pubmed:dateCreated | 1994-5-6 | lld:pubmed |
| pubmed-article:8151495 | pubmed:abstractText | Assessed longitudinally the effects of HIV infection and zidovudine on the adaptive behavior of 25 children with symptomatic disease (M age = 5.3 years; range = 1-12; 52% classified as encephalopathic) by parent report using the Vineland Adaptive Behavior Scales. Patients also were evaluated with an age-appropriate intelligence test and Q-sort Behavioral Rating Scale. Before treatment, encephalopathic children exhibited greater impairments in adaptive behavior than those without encephalopathy. After 6 months of zidovudine, all behavioral domains (communication, daily living, socialization) except for motor skills showed overall significant improvement. Children with or without encephalopathy showed a similar degree of change. Improvements in adaptive behavior correlated with increases in cognitive ability and decreases in severity of aberrant social-emotional behavior. | lld:pubmed |
| pubmed-article:8151495 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8151495 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8151495 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8151495 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8151495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8151495 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8151495 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:8151495 | pubmed:issn | 0146-8693 | lld:pubmed |
| pubmed-article:8151495 | pubmed:author | pubmed-author:PizzoP APA | lld:pubmed |
| pubmed-article:8151495 | pubmed:author | pubmed-author:MossH AHA | lld:pubmed |
| pubmed-article:8151495 | pubmed:author | pubmed-author:BrouwersPP | lld:pubmed |
| pubmed-article:8151495 | pubmed:author | pubmed-author:WoltersP LPL | lld:pubmed |
| pubmed-article:8151495 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8151495 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:8151495 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8151495 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8151495 | pubmed:pagination | 47-61 | lld:pubmed |
| pubmed-article:8151495 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:meshHeading | pubmed-meshheading:8151495-... | lld:pubmed |
| pubmed-article:8151495 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8151495 | pubmed:articleTitle | Adaptive behavior of children with symptomatic HIV infection before and after zidovudine therapy. | lld:pubmed |
| pubmed-article:8151495 | pubmed:affiliation | Pediatric Branch, National Cancer Institute, Bethesda, Maryland 20892. | lld:pubmed |
| pubmed-article:8151495 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8151495 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
